Pulmonary Vasoreactivity Test Response Prediction Model (AVT Response Predictor)
Patient and haemodynamic data
Enter baseline right-heart catheterization measurements. Add post-AVT measurements only when available.
Clinical interpretation
Pulmonary vasoreactivity testing is performed during right-heart catheterization to identify a subset of patients with PAH who may benefit from high-dose calcium-channel blocker therapy. It should be performed and interpreted in an experienced pulmonary hypertension centre.
Current adult acute-response definition
A positive response is a reduction in mPAP of at least 10 mmHg to an absolute mPAP of 40 mmHg or less, with cardiac output increased or unchanged.
Scope and limitations
- This tool calculates PVR and applies the current haemodynamic response definition to the supplied values.
- It does not estimate pre-test probability: the original point system and probability bands were not supported by a verifiable validated model.
- Routine AVT for identifying candidates for calcium-channel blockers is recommended for idiopathic, heritable, and drug-associated PAH, not all PAH subtypes.
- Historical criteria should not be treated as interchangeable with current guideline criteria.
- Measurement quality, shunts, wedge-pressure reliability, and the clinical context can materially affect interpretation.
References
Humbert M, Kovacs G, Hoeper MM, et al.2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022;43:3618–3731. DOI: 10.1093/eurheartj/ehac237.Official guideline / DOI
Sitbon O, Humbert M, Jaïs X, et al.Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation. 2005;111(23):3105–3111. DOI: 10.1161/CIRCULATIONAHA.104.488486.Publication DOI
Rich S, Kaufmann E, Levy PS.The effect of high doses of calcium-channel blockers on survival in patients with primary pulmonary hypertension. N Engl J Med. 1992;327:76–81. DOI: 10.1056/NEJM199207093270203.Publication DOI
Clinical disclaimer: This calculator is an educational and decision-support aid, not an autonomous diagnostic or treatment tool. It must not replace right-heart catheterization standards, expert interpretation, current guidelines, or individualized clinical judgement. A positive acute response alone does not establish long-term calcium-channel blocker responsiveness.
PERSONAL WORKSPACE
Clinical notes
Document key findings and keep a structured record for your own reference.
Private by design. Notes are stored in this browser on this device only. They are not uploaded to Appcardio.
Export or share this note
PERSONAL WORKSPACE
My notes
Review, edit, or remove notes saved in this browser.
Stored locally on this device
QUALITY & SAFETY
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.
Please describe the issue clearly. For calculation concerns, include the input values and expected result where possible.